BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6515052)

  • 1. 99mTc-DL-Homocysteine, a potential tumor imaging agent.
    Tamemasa O; Goto R; Takeda A; Yano M
    Radioisotopes; 1984 Sep; 33(9):636-8. PubMed ID: 6515052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor detection with some 99mTc-labeled S-containing amino acids.
    Tamemasa O; Takeda A; Goto R
    Gan; 1984 May; 75(5):395-402. PubMed ID: 6745561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serum albumin as a carrier of 99mTc-complex to tumor tissue.
    Takeda A; Hibino T; Hoshino A; Okumura H; Okada S
    Int J Rad Appl Instrum B; 1991; 18(5):499-502. PubMed ID: 1917519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the nude mouse bearing a human tumor the best model for study of tumor-localizing radionuclides?
    Chatal JF; Diez E; Guihard D
    Int J Nucl Med Biol; 1981; 8(2-3):181-3. PubMed ID: 7319713
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of technetium-99m-liposomes in tumor imaging.
    Goins B; Klipper R; Rudolph AS; Phillips WT
    J Nucl Med; 1994 Sep; 35(9):1491-8. PubMed ID: 8071699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of tumor transport of 99mTc-DL-homocysteine, a possible tumor-imaging agent.
    Takeda A; Goto R; Okada S
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2570-5. PubMed ID: 3240478
    [No Abstract]   [Full Text] [Related]  

  • 7. [Usefulness of newly developed 99mTc-labeled STA-R12 for tumor imaging].
    Nakajima S; Shuke N; Aburano T; Ishikawa S; Sato J; Sakata I; Takemura T
    Kaku Igaku; 1994 Nov; 31(11):1379-83. PubMed ID: 7837707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy. Simplified preparation and evaluation.
    Thakur ML; DeFulvio JD
    J Immunol Methods; 1991 Mar; 137(2):217-24. PubMed ID: 2013698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling of the 99mtechnetium-nitrido group to monoclonal antibody and use of the complexes for the detection of tumors in mice.
    Kanellos J; Pietersz GA; McKenzie IF; Bonnyman J; Baldas J
    J Natl Cancer Inst; 1986 Aug; 77(2):431-9. PubMed ID: 3461204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical properties of technetium-99m-DL-homocysteine, a possible tumor-imaging agent.
    Takeda A; Goto R; Okada S
    Ann Nucl Med; 1988 Nov; 2(2):55-8. PubMed ID: 3275108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
    Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
    Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 99mTc-metallothionein-B72.3 and its F(ab')2 fragment.
    Brown BA; Dearborn CB; Drozynski CA; Sands H
    Cancer Res; 1990 Feb; 50(3 Suppl):835s-839s. PubMed ID: 2297730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 99mTc-labeled amino acids as radiopharmaceuticals. V. 99mTc complex of ethylenediamine-N,N-diacetic acid as a scintigraphic agent for tumors.
    Karube Y; Imoto T; Maeda T; Ohya M; Sugata S; Kono A; Mashiba H; Ichinose Y; Tanaka K; Kaku M
    Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3242-7. PubMed ID: 6421499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and animal imaging of 99mTc-hydrazinonicotinamide-folate as a new folate receptor-targeted tumor imaging agent].
    Liu LQ; Wang SZ; Li F; Teng B; Wang KZ; Qiu FC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):786-9. PubMed ID: 17260467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
    Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
    Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-HMPAO as a tumour blood flow agent.
    Hammersley PA; McCready VR; Babich JW; Coghlan G
    Eur J Nucl Med; 1987; 13(2):90-4. PubMed ID: 3609059
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhuang X; Zhao D; Yang P; Jia Y; Liang R; Zhao Q; Han C; Kinsella JM; Sheng R; Li J
    J Labelled Comp Radiopharm; 2018 Feb; 61(2):77-83. PubMed ID: 29140573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosynthesis and biological evaluation of L- and D-S-(3-[18F]fluoropropyl)homocysteine for tumor imaging using positron emission tomography.
    Bourdier T; Shepherd R; Berghofer P; Jackson T; Fookes CJ; Denoyer D; Dorow DS; Greguric I; Gregoire MC; Hicks RJ; Katsifis A
    J Med Chem; 2011 Mar; 54(6):1860-70. PubMed ID: 21351733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the biodistribution of four contrast agents in nude mice bearing NCI-H358 human lung cancer and evaluation of their value in diagnostic imaging].
    Zhang JY; Feng J; Li HM; Li XD; Jia HL
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):504-7. PubMed ID: 22093626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments.
    Berndorff D; Borkowski S; Moosmayer D; Viti F; Müller-Tiemann B; Sieger S; Friebe M; Hilger CS; Zardi L; Neri D; Dinkelborg LM
    J Nucl Med; 2006 Oct; 47(10):1707-16. PubMed ID: 17015908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.